Karyopharm

Biopharmaceutical company focused on developing and commercializing innovative cancer therapies

placeNewton, Massachusetts, United States calendar_todayFounded 2008 groups325 employees language karyopharm.com

Registered entities

Social engagement

Social engagement: 37.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Foresite Capital, Avidity Partners.

Investor typeCountShare
Venture capital633%
Private equity317%
Other / undisclosed950%

Recent activity

14 Jun 2026
Event
European Hematology Association (EHA) Annual Congress
28 May 2026
Event
Jefferies Global Healthcare Conference
27 May 2026
Event
ASCO26
Coming soon